Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Laboratoire Olivier from Fernelmont, company number BE0427882836, closed financial year 2025 with a result of € -231,369 after tax. For that financial year Laboratoire Olivier recorded revenue of € 48 million and equity of € 18.3 million. Compared with financial year 2024, the result moved from € -21,653 to € -231,369. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 5, 2026.
€ 18.3 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -231,369
▼ 969 % more loss than in 2024
Profit after tax over the fiscal year.
€ 5.5 million
▲ 29% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 14.5 million.
People and assets in 2025
250.8
▲ 25.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 16 million
▲ 10% vs 2024
€ 63,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1.9 million
▲ 204% vs 2024
Of which on lease € 1.1 million.
Debts at end 2025
€ 1.2 million
€ 176,154 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 4.1 million
▲ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 48 days on average.
€ 2.7 million
▲ 10% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 46,497,071 | € 44,214,754 | € 44,466,263 | € 48,012,005 | ▲ 8% |
| Profit after taxes | € 4,988,988 | € 941,056 | € -21,653 | € -231,369 | ▼ € 209,715 |
| Equity | € 27,580,701 | € 28,521,756 | € 18,500,103 | € 18,268,734 | ▼ 1% |
| Total debts | € 8,659,888 | € 9,746,174 | € 6,209,806 | € 8,092,861 | ▲ 30% |
| Cash | € 12,559,263 | € 15,055,212 | € 4,265,442 | € 5,485,829 | ▲ 29% |
| Land & buildings | € 1,229,294 | € 1,083,651 | € 938,007 | € 792,364 | ▼ 16% |
| Retained profit | € 23,788,657 | € 24,729,713 | € 14,708,059 | € 14,476,691 | ▼ 2% |
| Dividend | € 0 | € 0 | € 10,000,000 | € 0 | ▼ 100% |
| Bank debt | € 1,922,529 | € 1,767,003 | € 0 | € 1,157,883 | |
| Balance sheet total | € 36,335,589 | € 38,267,930 | € 24,709,909 | € 26,361,595 | ▲ 7% |
| Employees (FTE) | 221 | 222 | 225.7 | 250.8 | ▲ 25.1 |
Key figures of Laboratoire Olivier, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Laboratoire Olivier?
What happened at Laboratoire Olivier in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Raiko Kruger stepped down as director. NBB
- Marc-Alexandre BURMEISTER stepped down as director. NBB
- Natascha Von Buxhoeveden stepped down as director. NBB
- De Spiegeleer S. SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 231,369. Source: NBB ↗
- Raiko Kruger became a director. NBB
- Andreas BENKITSCH stepped down as director. NBB
- Marc-Alexandre BURMEISTER became a director. NBB
In short
From € 5 million profit in 2022 to € 231,369 loss in 2025.
Paid € 2.9 million in corporate taxes since 2022.
Best year ever: 2022, with € 5 million profit.
Paid out € 10 million in dividends to the owners in total.
A new publication or filing at Laboratoire Olivier? We notify you, reason included.
Follow Laboratoire OlivierDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of Centre d'Anatomie Pathologique et de Cytologie itself.
Directors
According to the 2025 annual accounts
Managing director · represented by Sandy De Spiegeleer
since 2022 · until 2028
Marc-Alexandre BURMEISTER
Director
since 2025 · until 2031
Andreas BENKITSCH
Director
since 2024 · until 2026
Wolf Frederik Kupatt
Director
since 2022 · until 2025
Raiko Kruger
Director
since 2026 · until 2032
Natascha Von Buxhoeveden
Director
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Rue Léopold Genicot, ZI, Nov. 16
5380 Fernelmont
Chaussée de Mons 47
1400 Nivelles
Active since 1 January 2016
Au-Gris-Han 6
6970 Tenneville
Active since 1 October 1985
Rue Lambert Dewonck 207
4432 Ans
Active since 1 October 1985
Rue des Foudriers(GHI) 8
7822 Ath
Active since 19 April 2021
Arianelaan 5
1200 Sint-Lambrechts-Woluwe
Active since 1 February 2025
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0427.882.836
- VAT number
- BE 0427.882.836
- Registered office
- Rue Léopold Genicot, ZI, Nov. 16, 5380 Fernelmont
- Names & denominations
- Laboratoire Olivier
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 September 1985
- Peppol
- Active · Active since 13 Oct 2025
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria